Invitrogen™ Human Factor XI Native Protein

Ref.: BL-RE-177383Manufacturer ref.: RP43075 50 μg
€267.00 excl. VAT

RP-43075 contains native human Factor XI protein. RP-43075 may be used as a positive control in many immunological assays. The product is of human blood/plasma origin. Although the starting material was tested prior to initiation of the…

Accession number
P03951
Concentration
7.0 mg/mL
For use with (application)
Control
Formula
50% water with 50% glycerol and no preservative
Genetic identification (Enter)
2160
Brand
Invitrogen

RP-43075 contains native human Factor XI protein. RP-43075 may be used as a positive control in many immunological assays. The product is of human blood/plasma origin. Although the starting material was tested prior to initiation of the…

RP-43075 contains native human Factor XI protein. RP-43075 may be used as a positive control in many immunological assays. The product is of human blood/plasma origin. Although the starting material was tested prior to initiation of the manufacturing process, and was found negative or nonreactive for anti-HIV-1/2, HIV-1 antigen(s), HBsAg, STS, anti-HCV, anti-HBcore and anti-HTLV I & II, extreme caution should be used when handling this material as there is a margin of error in all tests. This product is to be used for IN VITRO research purposes only, and is not intended for clinical or diagnostic use!

This gene encodes coagulation factor XI of the blood coagulation cascade. This protein is present in plasma as a zymogen, which is a unique plasma coagulation enzyme because it exists as a homodimer consisting of two identical polypeptide chains linked by disulfide bonds. During activation of the plasma factor XI, an internal peptide bond is cleaved by factor XIIa (or XII) in each of the two chains, resulting in activated factor XIa, a serine protease composed of two heavy and two light chains held together by disulfide bonds. This activated plasma factor XI triggers the middle phase of the intrisic pathway of blood coagulation by activating factor IX. Defects in this factor lead to Rosenthal syndrome, a blood coagulation abnormality.

Species

Species: Human.

Conjugate

Conjugated: Unconjugated.

Conservation

Storage: -20°C, Avoid Freeze/Thaw Cycles.

Formulation

Concentration: 7.0 mg/mL.

Regulatory status

Research only (RUO).

Technical specifications

General
BrandInvitrogen
Supplier ref. (Fisher Scientific)11564111
Specifications
Accession numberP03951
Concentration7.0 mg/mL
For use with (application)Control
Formula50% water with 50% glycerol and no preservative
Genetic identification (Enter)2160
NomHuman Factor XI
Quantity50 μg
SourceHuman
Regulatory statusRUO
Gene aliases1600027G01Rik; AI503996; Cf11; Coagulation factor XI; Coagulation factor XIa heavy chain; Coagulation factor XIa light chain; F11; FXI; LRRGT00086; antecedent thromboplastin plasma; PTA
Common nameFactor XI
Gene symbol(s)F11
Biological activitySpecific Activity =372 U/mg; determined by Factor XI clotting assay where 1 U equals the Factor XI activity in 1 mL of normal human plasma.
ConjugateUnconjugated
SpeciesHuman
ShapeLiquid
Protein subtypeNative
Physical characteristics
Molecular weight160 kDa
Storage and shipping
Content and storage-20°C, Avoid Freeze/Thaw Cycles

Origin and customs

Manufacturer ref.RP43075
Country of originUnited States
HS customs code3002 15 00 00
A question or a specific configuration?
Contact us for a quote.